If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

4 Oct 2022 07:00

RNS Number : 6145B
Synectics PLC
04 October 2022
 

 

 

RNS

 

4 October 2022

 

 

Synectics plc

("Synectics" or the "Company")

 

Director/PDMR dealings

 

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, has been notified that on 3 October 2022, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased a total of 13,869 ordinary shares of 20 pence each in the Company ("Ordinary Shares") at a price of £1.10 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2022.

 

Under the terms of the ESAP, participating members, including employees and a Director of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per share on the date of purchase which was £1.10.

 

As a result of this purchase, the Company has been notified that the following Executive Director and PDMR have acquired the following interests in Ordinary Shares:

 

 

 

Name

 

 

Position

 

 

Status

Number of Ordinary Shares purchased by the Trustee

Paul Webb

Chief Executive

Executive Director

819

Greg Alcorn

Divisional Director

PDMR

818

 

Following these purchases, the interests of Messrs Webb and Alcorn in the shares of the Company are as follows:

 

Name

 

Number of Ordinary Shares Held

Interest in Ordinary Shares in Share Schemes

 

 

Resultant Total Interest

 

 

% of Issued Share Capital

Paul Webb

57,115

513,176

570,291

3.20

Greg Alcorn

0

47,427

47,427

0.27

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Claire Stewart, Company Secretary

email: legalandsecretarial@synecticsplc.com

www.synecticsplc.com

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / David Coaten

 

 

 Ends

 

About Synectics plc

 

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

 

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The Group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.

 

Find out more at www.synecticsplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASEDEDAAFFA
Date   Source Headline
13th Dec 20171:43 pmRNSHolding(s) in Company
12th Dec 20177:00 amRNSTrading Update
1st Dec 20175:35 pmRNSAIM Disclosure Update
30th Oct 20174:40 pmRNSDirector/PDMR Shareholding
16th Oct 20173:23 pmRNSDirector/PDMR Shareholding
22nd Sep 20173:02 pmRNSDirector/PDMR Shareholding
21st Sep 20173:58 pmRNSHolding(s) in Company
6th Sep 201710:01 amRNSDirector/PDMR Shareholding
29th Aug 20175:11 pmRNSHolding(s) in Company
18th Jul 20177:00 amRNSInterim Results
6th Jul 20177:00 amRNSNotification of Interim Results
6th Jun 20175:54 pmRNSRe-appointment of Auditor
26th May 201710:04 amRNSDirector/PDMR Shareholding
28th Apr 20174:01 pmRNSDirector/PDMR Shareholding
27th Apr 20171:08 pmRNSResult of AGM
27th Apr 20177:00 amRNSAGM Statement
11th Apr 20177:00 amRNSContract Wins
24th Mar 20172:43 pmRNSPosting of Annual Report and AGM Notice
7th Mar 20179:55 amRNSDirector/PDMR Shareholding
2nd Mar 201711:32 amRNSDirector/PDMR Shareholding
21st Feb 20177:00 amRNSFinal Results
30th Jan 20177:00 amRNSNotification of Final Results
10th Jan 20177:00 amRNSAdoption of Financial Reporting Standard 101
8th Dec 20167:00 amRNSYear End Trading Update
21st Oct 20162:20 pmRNSDirector/PDMR Shareholding
19th Jul 20167:01 amRNSContract Wins
19th Jul 20167:00 amRNSInterim Results
12th Jul 20163:25 pmRNSDirector/PDMR Shareholding
10th Jun 20167:00 amRNSNotification of Interim Results
9th Jun 20167:00 amRNSInvestor and Analyst Site Visit
3rd May 20164:33 pmRNSDirector/PDMR Shareholding
27th Apr 201612:00 pmRNSResult of AGM
27th Apr 20167:00 amRNSAGM Statement
24th Mar 20167:00 amRNSPosting of Annual Report and AGM Notice
3rd Mar 20164:20 pmRNSHolding(s) in Company
2nd Mar 201612:36 pmRNSDirector/PDMR Shareholding
1st Mar 20164:48 pmRNSDirector/PDMR Shareholding
24th Feb 20167:01 amRNSFinal Results
24th Feb 20167:00 amRNSContract Win
23rd Feb 20167:00 amRNSDirectorate Change
10th Feb 20167:00 amRNSContract Extension
8th Feb 20169:09 amRNSCorrection - Holding(s) in Company
5th Feb 20164:12 pmRNSNotification of Major Interest in Shares
5th Feb 20164:10 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSContract Win
28th Jan 20167:00 amRNSInternational airline selects Synergy 3
21st Jan 20167:00 amRNSMajor Contract Win
20th Jan 20167:00 amRNSNotification of Final Results
6th Jan 20164:52 pmRNSChange of Adviser Name
10th Dec 20157:00 amRNSYear End Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.